Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acetylcholine Iontophoresis As A New Challenge With Type 2 Diabetic Peripheral Neuropathy: A Possible New Therapy

NCT06219590 is registered in ClinicalTrials.gov with South Valley University as lead sponsor.

NCT NCT06219590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06219590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acetylcholine Iontophoresis As A New Challenge With Type 2 Diabetic Peripheral Neuropathy: A Possible New Therapy
Lead sponsor
South Valley University
Phase
Not applicable
Overall status
Unknown status
Start date
October 28, 2023
Completion date
January 30, 2024
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral neuropathy, type 2 diabetes mellitus